rosiglitazone has been researched along with isomethyleugenol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchard, SG; Gribble, GW; Honda, T; Leesnitzer, LM; Mangelsdorf, DJ; Plunket, KD; Porter, WW; Sporn, MB; Suh, N; Wang, Y; Willson, TM | 1 |
| Kapiotis, S; Krzyzanowska, K; Mittermayer, F; Pleiner, J; Roden, M; Schaller, G; Wolzt, M | 1 |
| Gao, H; He, J; Liang, Y; Yi, L; Yuan, D; Zhou, H | 1 |
| Hwang, JT; Kim, EJ; Park, UH; Um, SJ; Youn, H | 1 |
| Kim, EJ; Park, UH; Um, SJ; Youn, H | 1 |
1 trial(s) available for rosiglitazone and isomethyleugenol
| Article | Year |
|---|---|
Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction.
Topics: Acetylcholine; Adult; Anticoagulants; Arginine; C-Reactive Protein; Endothelium, Vascular; Fatty Acids, Nonesterified; Forearm; Heparin; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Methylation; Nitroglycerin; Plethysmography; Regional Blood Flow; Rosiglitazone; Thiazolidinediones; Vasculitis; Vasodilation; Vasodilator Agents | 2007 |
4 other study(ies) available for rosiglitazone and isomethyleugenol
| Article | Year |
|---|---|
A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Topics: 3T3 Cells; Adipocytes; Animals; Cell Differentiation; CREB-Binding Protein; Drug Synergism; Ligands; Methylation; Mice; Nicotinic Acids; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Oleanolic Acid; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Repressor Proteins; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcriptional Activation | 2000 |
Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients.
Topics: Adult; Aged; Calibration; Chromatography, Thin Layer; Diabetes Mellitus, Type 2; Esters; Fatty Acids; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Methylation; Middle Aged; Multivariate Analysis; Oleic Acid; Reproducibility of Results; Rosiglitazone; Thiazolidinediones; Time Factors | 2007 |
Kaempferol antagonizes adipogenesis by repressing histone H3K4 methylation at PPARĪ³ target genes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Histones; Kaempferols; Methylation; Mice; PPAR gamma; Rosiglitazone | 2022 |
Shikonin Binds and Represses PPARĪ³ Activity by Releasing Coactivators and Modulating Histone Methylation Codes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Cell Differentiation; Histones; Methylation; Mice; PPAR gamma; Rosiglitazone | 2023 |